Factors associated with completion of the human papillomavirus vaccine series.
about
Factors influencing completion of multi-dose vaccine schedules in adolescents: a systematic reviewThe Role of Physician Recommendations and Public Policy in Human Papillomavirus VaccinationsPatient and clinic factors associated with adolescent human papillomavirus vaccine utilization within a university-based health system.The influence of deductible health plans on receipt of the human papillomavirus vaccine series.A systematic review of measures used in studies of human papillomavirus (HPV) vaccine acceptability.Adherence to the HPV vaccine dosing intervals and factors associated with completion of 3 doses.HPV vaccine acceptance, utilization and expected impacts in the U.S.: Where are we now?Worsening disparities in HPV vaccine utilization among 19-26 year old women.Predictors of three dose on-time compliance with HPV4 vaccination in a disadvantaged, underserved, safety net population in the US Midwest.Quantifying clinical HPV4 dose inefficiencies in a safety net populationHPV vaccination among a community sample of young adult womenScaling up human papillomavirus vaccination: a conceptual framework of vaccine adherence.Human papillomavirus vaccine uptake among 9- to 17-year-old girls: National Health Interview Survey, 2008An update on human papillomavirus vaccine uptake among 11-17 year old girls in the United States: National Health Interview Survey, 2010Completion of the human papillomavirus vaccine series among insured females between 2006 and 2009Disparities in human papillomavirus vaccine completion among vaccine initiators.Uptake of free HPV vaccination among young women: a comparison of rural versus urban rates.Sexually related behaviors as predictors of HPV vaccination among young rural womenKnowledge about Human Papillomavirus and Time to Complete Vaccination among Vulnerable Female Youth.Role and uptake of human papillomavirus vaccine in adolescent health in the United StatesHuman papillomavirus vaccine coverage among females aged 11 to 17 in Texas counties: an application of multilevel, small area estimation.Focus group discussions in community-based participatory research to inform the development of a human papillomavirus (HPV) educational intervention for Latinas in San Diego.Racial and ethnic differences in HPV knowledge, attitudes, and vaccination rates among low-income African-American, Haitian, Latina, and Caucasian young adult women.Patient adherence to three dose completion of the quadrivalent human papillomavirus (HPV) vaccine in a private practice.Ethnic differences in predictors of HPV vaccination: comparisons of predictors for Latina and non-Latina White women.Patient-provider communication and human papillomavirus vaccine acceptance.Human Papillomavirus Vaccine Knowledge and Attitudes, Preventative Health Behaviors, and Medical Mistrust Among a Racially and Ethnically Diverse Sample of College Women.Sexual Health Care Services among Young Adult Sexual Minority Women.Hispanic mothers' beliefs regarding HPV vaccine series completion in their adolescent daughters.
P2860
Q28067076-FB937F18-E491-40DA-A22E-00809E285EA2Q30054300-EF4D5FD3-2874-4A07-960D-E9085F7B3241Q33918719-26C024C8-9006-446C-ACF6-53E8AB8CC217Q34081680-D2A18C0B-0B9B-4F38-8E91-58C316C4E840Q34425685-AE3ED456-7076-4357-BE56-76251A4D9EE9Q34439784-4FED8AFC-20A1-41A2-BF04-0C3C13F4CD3EQ34440994-7C2DC4EB-721C-47D9-BB3E-CD1230919D25Q34455750-EAF61507-3DF8-4F7F-8D2A-3CBE9D43AF82Q34949073-7B89DB6F-4056-4103-A996-682807E755BBQ35040145-40250381-C626-4815-ACF1-18BB70AC5158Q35112562-1A089A49-8C7F-40DA-9A62-4A9DB204F4AFQ35121855-1E100AB5-5D44-4DFE-9F23-8CEF4AE17499Q35231562-B1CFA9B3-5D5C-4845-8430-D4BD065F85C4Q36029073-9EAE0D29-0188-47D1-8D95-5E2923DE5890Q36133754-CD06EE58-2F52-4BA7-AF90-0D583F01256BQ36416348-39255CD7-8E23-4B05-AFC2-37004EDACDA4Q36580580-9127A8A5-2D66-4544-85CD-6FFDFA668040Q36635782-BB367C50-0E16-487B-8E5B-C4F2761EF5F1Q36731354-FF24B4DF-835A-43D8-9E45-8030CE3DB51FQ37244355-EFA4BE71-5EDE-4DD5-9497-E6A6150661EFQ37362659-26442E1B-2A63-4636-9D3F-4DE841616751Q37403045-D8B46CE5-D90F-4AEB-AA40-A9B6F1AC940FQ37632069-F0E0E0AA-A5D8-47FF-B445-21B65F89ECB9Q38023254-CC52F53A-1560-41A5-A9C4-F4DC98AAAF08Q39543237-4320CA06-F18A-4580-9677-4B9697EC7863Q39838282-B267F57E-F992-4963-983A-59BF0F080B3BQ40008010-50368CE7-03B4-4F37-92C0-597EA2BCD8AFQ47663278-D8FE69F1-5EBF-4C96-B440-B9CF47A31D48Q50461714-0DF609E2-A9EC-40EC-B924-104268FDC95C
P2860
Factors associated with completion of the human papillomavirus vaccine series.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Factors associated with completion of the human papillomavirus vaccine series.
@en
Factors associated with completion of the human papillomavirus vaccine series.
@nl
type
label
Factors associated with completion of the human papillomavirus vaccine series.
@en
Factors associated with completion of the human papillomavirus vaccine series.
@nl
prefLabel
Factors associated with completion of the human papillomavirus vaccine series.
@en
Factors associated with completion of the human papillomavirus vaccine series.
@nl
P2093
P2860
P356
P1433
P1476
Factors associated with completion of the human papillomavirus vaccine series.
@en
P2093
Carmen Radecki Breitkopf
Daniel Breitkopf
Richard Rupp
Susan L Rosenthal
Tara P L Neubrand
P2860
P304
P356
10.1177/0009922809337534
P577
2009-05-29T00:00:00Z